AMTX vs VTR · rev $77.2M vs P/E 149, rev $4.92B
Aemetis Inc (AMTX) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
AMTX currently screens at market cap $158.3M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the AMTX and VTR stock pages for the full models.
Not investment advice.